1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Pc-ASPECTS on follow-up images and HT rates for categorized CTASI pc-ASPECTS groups
OutcomeCTASI pc-ASPECTSRisk Ratio (95% CI)P value
8–100–7
All patients, N2122
F/U pc-ASPECTS score, median (range)7 (3–10)3.5 (0–9)−< .001
HT, % (n)9.5 (2)27.3 (6)0.4 (0.1–1.5).24
PH, % (n)4.8 (1)18.2 (4)0.3 (0.03–2.2).34
HI, % (n)4.8 (1)9.1 (2)0.5 (0.1–5.4)1.00
Patients with thrombolysis, N1619
F/U pc-ASPECTS score, median (range)7 (3–10)3 (0–7)−< .001
HT, % (n)12.5 (2)31.6 (6)0.4 (0.1–1.7).24
PH, % (n)6.3 (1)21.1 (4)0.3 (0.04–2.4).35
HI, % (n)6.3 (1)10.6 (2)0.6 (0.1–6.0)1.00
  • Note:—F/U denotes follow-up; HT, hemorrhagic transformation; PH, parenchymal hematoma; HI, hemorrhagic infarction.